Agency Forms Undergoing Paperwork Reduction Act Review, 58736-58737 [2024-15967]

Download as PDF 58736 Federal Register / Vol. 89, No. 139 / Friday, July 19, 2024 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Type of respondents Number of respondents Form name Self-Perception Surveys and other Structured Questions: Perceived comfort level with technology, perceived safety and trust level with technology, perceived fatigue while interacting with technology, etc. Biomechanics measurements: Force plate, strain gauges, stopwatch, accelerometers (including dataloggers), electromyography sensors human/ equipment interaction forces, whole-body motion, Electromyography (EMG) for muscle activity, Near-infrared spectroscopy (NIRS) for muscle oxygenation, etc. Task Performance Measures: Measures recorded using various virtual reality systems (e.g., Vive, Meta quest) and components (e.g., controllers) that quantify the subjects’ performance such as time to complete, errors, movement path, and omissions. Eye Tracking Measures: Recorded using various virtual reality glasses (e.g., Ergoneers) to assess eyes-offtask time and recognition in response to simulated environments designed to assess integration of new robotic technologies and design set-up. Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2024–15966 Filed 7–18–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–24–0978] ddrumheller on DSK120RN23PROD with NOTICES1 Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled ‘‘Emerging Infections Program (EIP)’’ to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on February 29, 2024 to obtain comments from the public and affected agencies. CDC received one non-substantive comment. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the VerDate Sep<11>2014 18:53 Jul 18, 2024 Jkt 262001 functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/ do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hours) 4,000 6 10/60 2,000 4 30/60 2,000 12 15/60 2,000 12 15/60 Proposed Project Emerging Infections Program (EIP) (OMB Control No. 0920–0978, Exp. 2/ 28/2026)—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Emerging Infections Programs (EIP) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions; local health departments; public health and clinical laboratories; infection control professionals; and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases. Activities of the EIPs fall into the following general categories: (1) active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease. Activities in the EIP Network to which all applicants must participate are: E:\FR\FM\19JYN1.SGM 19JYN1 58737 Federal Register / Vol. 89, No. 139 / Friday, July 19, 2024 / Notices • Active Bacterial Core surveillance (ABCs): active population-based laboratory surveillance for invasive bacterial diseases. • Foodborne Diseases Active Surveillance Network (FoodNet): active population-based laboratory surveillance to monitor the incidence of select enteric diseases. • Influenza: active population-based surveillance for laboratory confirmed influenza-related hospitalizations. • Healthcare-Associated InfectionsCommunity Interface (HAIC) surveillance: active population-based surveillance for healthcare-associated pathogens and infections. A Revision is being submitted to make existing collection instruments clearer and to add several new forms specifically surveying laboratory practices. These forms will allow the EIP to better detect, identify, track changes in laboratory testing methodology, gather information about laboratory utilization in the EIP catchment area to ensure that all cases are being captured, and survey EIP staff to evaluate program quality. CDC requests OMB approval for an estimated 41,483 annual burden hours. There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Form No. Form name State Health Department ..................... ABC.100.1 ....... ABC.100.2 ....... ABCs Case Report Form .............................................. ABCs Invasive Pneumococcal Disease in Children and Adults Case Report Form. ABCs H. influenzae Neonatal Sepsis Expanded Surveillance Form. ABCs Severe GAS Infection Supplemental Form ........ ABCs Neonatal Infection Expanded Tracking Form ..... FoodNet Campylobacter ............................................... FoodNet Cyclospora ..................................................... FoodNet Listeria monocytogenes ................................. FoodNet Salmonella ...................................................... FoodNet Shiga toxin producing E. coli ......................... FoodNet Shigella ........................................................... FoodNet Vibrio .............................................................. FoodNet Yersinia .......................................................... FoodNet Hemolytic Uremic Syndrome ......................... FoodNet Clinical Laboratory Practices and Testing Volume. FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form. FluSurv-Net Influenza Hospitalization Surveillance Project Vaccination Phone Script and Consent Form (English/Spanish). FluSurv-Net Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)and notification letter. FluSurv-NET Laboratory Survey ................................... HAIC—Multi-site Gram-Negative Surveillance Initiative (MuGSI) Case Report Form (CRF). HAIC MuGSI CA CP–CRE Health interview ................ HAIC MuGSI Supplemental Surveillance Officer Survey. HAIC—Invasive Staphylococcus aureus Infection Case Report Form. HAIC—Invasive Staphylococcus aureus Laboratory Survey. HAIC—Invasive Staphylococcus aureus Supplemental Surveillance Officers Survey. HAIC—CDI Case Report and Treatment Form ............ HAIC—Annual Survey of Laboratory Testing Practices for C. difficile Infections. HAIC—CDI Annual Surveillance Officers Survey ......... HAIC—Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey (LTCF). HAIC Candidemia Case Report Form .......................... HAIC—Laboratory Testing Practices for Candidemia Questionnaire. HAIC Death Ascertainment Project .............................. ABC.100.3 ....... ABC.100.4 ....... ABC.100.5 ....... FN.200.1 ......... FN.200.2 ......... FN.200.3 ......... FN.200.4 ......... FN.200.5 ......... FN.200.6 ......... FN.200.7 ......... FN.200.8 ......... FN.200.9 ......... FN.200.10 ....... FSN.300.1 ....... FSN.300.2 ....... FSN.300.3 ....... FSN.300.4 ....... HAIC.400.1 ...... HAIC.400.2 ...... HAIC.400.3 ...... HAIC.400.4 ...... HAIC.400.5 ...... HAIC.400.6 ...... HAIC.400.7 ...... HAIC.400.8 ...... HAIC.400.9 ...... HAIC.400.10 .... HAIC.400.11 .... HAIC.400.12 .... HAIC.400.13 .... ddrumheller on DSK120RN23PROD with NOTICES1 Number of respondents Type of respondent Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2024–15967 Filed 7–18–24; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 18:53 Jul 18, 2024 Jkt 262001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\19JYN1.SGM 19JYN1 Number of responses per respondent Average burden per response (in hours) 10 10 809 127 20/60 10/60 10 6 10/60 10 10 10 10 10 10 10 10 10 10 10 10 136 37 970 42 16 855 290 234 46 55 10 70 20/60 20/60 21/60 10/60 20/60 21/60 20/60 10/60 10/60 10/60 1 10/60 15 576 25/60 13 16 10/60 13 126 5/60 15 11 16 1,581 10/60 29/60 10 11 10 1 30/60 20/60 10 788 29/60 10 11 9/60 10 1 11/60 10 10 1,650 16 38/60 17/60 10 10 1 45 15/60 5/60 10 10 170 20 40/60 14/60 10 8 24

Agencies

[Federal Register Volume 89, Number 139 (Friday, July 19, 2024)]
[Notices]
[Pages 58736-58737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15967]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-0978]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Emerging Infections Program (EIP)'' to the 
Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on February 29, 2024 to obtain 
comments from the public and affected agencies. CDC received one non-
substantive comment. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Emerging Infections Program (EIP) (OMB Control No. 0920-0978, Exp. 
2/28/2026)--Revision--National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Emerging Infections Programs (EIP) are population-based centers 
of excellence established through a network of state health departments 
collaborating with academic institutions; local health departments; 
public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases. Activities of the EIPs fall into the 
following general categories: (1) active surveillance; (2) applied 
public health epidemiologic and laboratory activities; (3) 
implementation and evaluation of pilot prevention/intervention 
projects; and (4) flexible response to public health emergencies. 
Activities of the EIPs are designed to: (1) address issues that the EIP 
network is particularly suited to investigate; (2) maintain sufficient 
flexibility for emergency response and new problems as they arise; (3) 
develop and evaluate public health interventions to inform public 
health policy and treatment guidelines; (4) incorporate training as a 
key function; and (5) prioritize projects that lead directly to the 
prevention of disease. Activities in the EIP Network to which all 
applicants must participate are:

[[Page 58737]]

     Active Bacterial Core surveillance (ABCs): active 
population-based laboratory surveillance for invasive bacterial 
diseases.
     Foodborne Diseases Active Surveillance Network (FoodNet): 
active population-based laboratory surveillance to monitor the 
incidence of select enteric diseases.
     Influenza: active population-based surveillance for 
laboratory confirmed influenza-related hospitalizations.
     Healthcare-Associated Infections-Community Interface 
(HAIC) surveillance: active population-based surveillance for 
healthcare-associated pathogens and infections.
    A Revision is being submitted to make existing collection 
instruments clearer and to add several new forms specifically surveying 
laboratory practices. These forms will allow the EIP to better detect, 
identify, track changes in laboratory testing methodology, gather 
information about laboratory utilization in the EIP catchment area to 
ensure that all cases are being captured, and survey EIP staff to 
evaluate program quality.
    CDC requests OMB approval for an estimated 41,483 annual burden 
hours. There is no cost to respondents other than their time.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                             Number of    Average burden
                Type of respondent                           Form No.                   Form name            Number of     responses per   per response
                                                                                                            respondents     respondent      (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Health Department...........................  ABC.100.1.................  ABCs Case Report Form...              10             809           20/60
                                                    ABC.100.2.................  ABCs Invasive                         10             127           10/60
                                                                                 Pneumococcal Disease in
                                                                                 Children and Adults
                                                                                 Case Report Form.
                                                    ABC.100.3.................  ABCs H. influenzae                    10               6           10/60
                                                                                 Neonatal Sepsis
                                                                                 Expanded Surveillance
                                                                                 Form.
                                                    ABC.100.4.................  ABCs Severe GAS                       10             136           20/60
                                                                                 Infection Supplemental
                                                                                 Form.
                                                    ABC.100.5.................  ABCs Neonatal Infection               10              37           20/60
                                                                                 Expanded Tracking Form.
                                                    FN.200.1..................  FoodNet Campylobacter...              10             970           21/60
                                                    FN.200.2..................  FoodNet Cyclospora......              10              42           10/60
                                                    FN.200.3..................  FoodNet Listeria                      10              16           20/60
                                                                                 monocytogenes.
                                                    FN.200.4..................  FoodNet Salmonella......              10             855           21/60
                                                    FN.200.5..................  FoodNet Shiga toxin                   10             290           20/60
                                                                                 producing E. coli.
                                                    FN.200.6..................  FoodNet Shigella........              10             234           10/60
                                                    FN.200.7..................  FoodNet Vibrio..........              10              46           10/60
                                                    FN.200.8..................  FoodNet Yersinia........              10              55           10/60
                                                    FN.200.9..................  FoodNet Hemolytic Uremic              10              10               1
                                                                                 Syndrome.
                                                    FN.200.10.................  FoodNet Clinical                      10              70           10/60
                                                                                 Laboratory Practices
                                                                                 and Testing Volume.
                                                    FSN.300.1.................  FluSurv-Net Influenza                 15             576           25/60
                                                                                 Hospitalization
                                                                                 Surveillance Network
                                                                                 Case Report Form.
                                                    FSN.300.2.................  FluSurv-Net Influenza                 13              16           10/60
                                                                                 Hospitalization
                                                                                 Surveillance Project
                                                                                 Vaccination Phone
                                                                                 Script and Consent Form
                                                                                 (English/Spanish).
                                                    FSN.300.3.................  FluSurv-Net Influenza                 13             126            5/60
                                                                                 Hospitalization
                                                                                 Surveillance Project
                                                                                 Provider Vaccination
                                                                                 History Fax Form
                                                                                 (Children/Adults)and
                                                                                 notification letter.
                                                    FSN.300.4.................  FluSurv-NET Laboratory                15              16           10/60
                                                                                 Survey.
                                                    HAIC.400.1................  HAIC--Multi-site Gram-                11           1,581           29/60
                                                                                 Negative Surveillance
                                                                                 Initiative (MuGSI) Case
                                                                                 Report Form (CRF).
                                                    HAIC.400.2................  HAIC MuGSI CA CP-CRE                  10              10           30/60
                                                                                 Health interview.
                                                    HAIC.400.3................  HAIC MuGSI Supplemental               11               1           20/60
                                                                                 Surveillance Officer
                                                                                 Survey.
                                                    HAIC.400.4................  HAIC--Invasive                        10             788           29/60
                                                                                 Staphylococcus aureus
                                                                                 Infection Case Report
                                                                                 Form.
                                                    HAIC.400.5................  HAIC--Invasive                        10              11            9/60
                                                                                 Staphylococcus aureus
                                                                                 Laboratory Survey.
                                                    HAIC.400.6................  HAIC--Invasive                        10               1           11/60
                                                                                 Staphylococcus aureus
                                                                                 Supplemental
                                                                                 Surveillance Officers
                                                                                 Survey.
                                                    HAIC.400.7................  HAIC--CDI Case Report                 10           1,650           38/60
                                                                                 and Treatment Form.
                                                    HAIC.400.8................  HAIC--Annual Survey of                10              16           17/60
                                                                                 Laboratory Testing
                                                                                 Practices for C.
                                                                                 difficile Infections.
                                                    HAIC.400.9................  HAIC--CDI Annual                      10               1           15/60
                                                                                 Surveillance Officers
                                                                                 Survey.
                                                    HAIC.400.10...............  HAIC--Emerging                        10              45            5/60
                                                                                 Infections Program C.
                                                                                 difficile Surveillance
                                                                                 Nursing Home Telephone
                                                                                 Survey (LTCF).
                                                    HAIC.400.11...............  HAIC Candidemia Case                  10             170           40/60
                                                                                 Report Form.
                                                    HAIC.400.12...............  HAIC--Laboratory Testing              10              20           14/60
                                                                                 Practices for
                                                                                 Candidemia
                                                                                 Questionnaire.
                                                    HAIC.400.13...............  HAIC Death Ascertainment              10               8              24
                                                                                 Project.
--------------------------------------------------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-15967 Filed 7-18-24; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.